Health care stocks gained Wednesday afternoon, with the NYSE Health Care Index up 0.4% and the Health Care Select Sector SPDR Fund (XLV) adding 0.5%.
The iShares Biotechnology ETF (IBB) increased 0.4%.
In corporate news, Trinity Biotech (TRIB) shares jumped about 28% after it said Wednesday that it has received regulatory approval to begin offshore and outsourced manufacturing of its TrinScreen HIV rapid test.
Tharimmune (THAR) shares surged 103% after it said Wednesday that results from an analysis of its lead drug candidate TH104 showed that it could potentially be used as a countermeasure for military personnel and chemical incident responders exposed to high-potency opioids, including weaponized fentanyl.
CVS Health's (CVS) Caremark unit has been ordered to pay about $289.9 million in a whistleblower case involving Medicare fraud claims, according to a court ruling on Tuesday. CVS shares increased 0.2%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.